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However, because full recovery of cardiac function is seen in survivors at 7-10 days (1), it seems that functional rather than structural changes are responsible for intrinsic myocardial depression (2) . At a subcellular level, as sepsis-induced energy demands outstrip the supply, adaptive changes are presumed to trigger a molecular shift in the cellular substrate utilization and contractile function (2) . Downregulation of bioenergy requirements is hypothesized to enable cardiomyocytes to circumvent death, thus explaining improved survival in prolonged sepsis. In this context, sepsis-induced mitochondria dysfunction and damage appear to be the critical modulating events coordinating cellular adaptive responses (rather than maladaptive) to compounding stressors (3) . Indeed, the degree of mitochondrial dysfunction measured in skeletal muscle biopsies correlates with outcome in patients with severe sepsis (4) (5) (6) . Furthermore, mitochondrial damage in the heart has been found in human autopsy specimens of patients with severe sepsis (7) .
Perixisome proliferator-activated receptor- coactivator 1- (PGC-1) is a transcriptional coactivator that plays a key regulator role in mitochondrial metabolism and biogenesis. It functions as a transcripIt functions as a transcriptional coactivator for various transcription factors, which are involved in energy metabolism and muscle fiber expression (8, 9) . We have recently shown that the molecular switch favoring the expression of fetal isoforms of contraction-related proteins known to occur after sepsis-induced Objectives: We hypothesized that resveratrol administration would reverse sepsis-dependent downregulation of peroxisome proliferator activated receptor-g coactivator 1a, preserve mitochondrial integrity, and rescue animals from sepsis-induced myocardial failure.
myocardial depression is associated with downregulation of PGC-1 and related transcription factors in an inducible nitric oxide synthase (iNOS)-dependent manner (8, 9) . In several cardiac pathological states, downregulation of PGC-1 and its target genes is shown to correlate with severity (10) (11) (12) .
Resveratrol (ResV) is a polyphenol, mostly known as a constituent of red wine, that has positive effects in a wide variety of disease states (13, 14) . It has been implicated in the regulation of expression and activation of key transcription factors and their cofactors such as PGC-1 (15, 16) . In skeletal muscle, ResV treatment resulted in upregulation of PGC-1 and consequent increase in mitochondrial size, DNA content, and enhanced mitochondrial enzymatic activity.
In this study, we hypothesized that ResV administration would reverse sepsisdependent downregulation of PGC-1, preserve mitochondrial integrity, and rescue animals from sepsis-induced myocardial failure. We performed cecal ligation and puncture (CLP) in mice to induce chronic sublethal polymicrobial sepsis. Forty-eight hrs after CLP, cardiac performance was established using echocardiography. Mitochondrial integrity was evaluated with electron microscopy, and changes in gene expression associated with ResV administration and improvement of myocardial function were evaluated with microarray analysis and quantitative real-time polymerase chain reaction.
MATERIALS AND METHODS
See details in Supplemental Digital Content 1, http://links.lww.com/CCM/A418.
Animal Experiment
Male C57/BL6 mice (8-10 wks, wild type; Jackson Laboratory, Bar Harbor, ME) were randomly assigned to CLP or sham operation (8) . Experiments were conducted in accordance with standard operating procedures of the Department of Comparative Medicine University of Toronto, Toronto, Canada. Pro-tocol was approved by the Institutional Animal Care and Use Committee at St. Michael's Hospital.
Mice were randomized to receive ResV (30 or 60 mg/kg) (Cat#554325, Calbiochem, Darmstadt, Germany) or vehicle 1 ml saline subcutaneously after surgery and at 16, 24 and 40 hrs. Dose and timing was determined by preliminary experiments. At 48hrs, mice underwent echocardiography, and were sacrificed by cardiac puncture. Hearts were removed fixed or snap-frozen. Investigators performing assessments were blinded to treatment assignment.
Cardiac Echocardiography
Heart rate, left ventricular end diastolic diameter, end systolic diameter, end diastolic area, and end systolic area were measured. Fractional shortening fractional area change, and left ventricular ejection fraction were calculated.
Pathology
Scoring of tissue injury was performed on formalin-fixed, paraffin-embedded whole heart sections (four mice randomly selected from each group) stained with hematoxylin and eosin (17) . Ultrastructural changes were determined by an electron microscopy muscle pathologist blinded to group assignment (n  3 animals/group; five to eight sections/animal). Qualitative and semiquantitative injury assessment was adapted from Bishop et al (18) The grading data were not subjected to statistical analysis.
RNA Isolation and Quantitative Real-Time Polymerase Chain Reaction
Total RNA from whole hearts were isolated and purified (17) . Primer sequences are presented in Supplemental 
Microarray Analysis
A total of 300 ng of messenger RNA from all hearts (four animals/group) was hybridized to Illumina Mouse WG 6v1.1 chip. Data was processed using R-Project for Bioconductor (19) and normalized using variance-stabilizing transformation (VST) (20) . We performed one-class analysis in SAM [significant analysis of microarray] (21) to filter out non-specific genes. A total of 18,586 probes significantly changed relative to the standard deviation of repeated measurements of each probe across all experiments (FDR < 0.9%, delta 7.1888) were used for gene set enrichment analysis (GSEA, http://www.broadinstitute.org/gsea/ index.jsp) (22) (23) (24) . An FDR of 25% was used as the cut-off for significance (23, 25) . Specific pathways were visualized using Ingenuity Pathway Analysis (IPA, Ingenuity Systems, Inc. Redwood City, CA).
Primary Cardiomyocyte Isolation and Protein Detection
Primary cultures of neonatal cardiomyocytes were prepared from Sprague-Dawley rats (26, 27) . Once isolated, cardiomyocytes were treated with lipolysaccharide (LPS, 1mg/ml), Resveratrol (ResV, 50 mM), LPS+ResV or vehicle alone for 48 hrs. The relative abundance of PGC-1a, Nrf2 (C-20), and -actin was detected by Western blot (17, 28) .
Antibodies
PGC-1, Nrf2 (C-20), -actin, and horseradish peroxidase conjugated secondary antibodies to mouse or rabbit immunoglobulins were purchased from Santa Cruz Biotech (Santa Cruz, CA). Other chemicals were purchased from Sigma or Fisher Scientific.
Statistics
No differences in mortality were found between the two dosages of ResV using log-rank data; data were therefore analyzed collectively (Supplemental Fig. 1 
RESULTS

Effects of ResV on Survival
Animals became lethargic, stopped grooming, and developed diarrhea after CLP. No behavioral difference was seen between vehicle-and ResV-treated animals. Forty-eight hours after the induction of sepsis, weight loss was not different between the groups (data not shown). Survival in the vehicle-treated group was 48% and treatment with ResV (30 mg/kg or 60 mg/kg) did not lead to a significant improvement in survival ( 
ResV Administration Improves Myocardial Contractility
At 48 hrs, exposure to CLP resulted in decreased myocardial contractility in the vehicle compared to the ResV-treated group. ResV-treated mice had better fractional shortening (p  .007) (Fig. 1B) , fractional area change (p  .017) (Fig. 1C) , and ejection fraction (p  .011) (Fig. 1D ) than vehicle-treated animals (Supplemental diameter and left ventricular end-diastolic area. Heart rate did not differ between the groups (Fig. 1E) .
Treatment with ResV Attenuates CLP-Induced Myocardial Ultrastructural Injury
After CLP-induction, hearts from vehicle treated mice showed grade 2-3 injury, i.e. focal lesions and myocardial edema, extending over a wider area of the left ventricle with right ventricular involvement (Supplemental Fig. 2 , Supplemental Digital Content 1, http:// links.lww.com/CCM/A421). ResV-treated mice developed grade 1-2 injury (focal areas of edema), but were generally spared from the diffuse myocardial edema. EM revealed ultrastructural changes in mitochondria from mice that developed moderate to severe myocardial depression (17) (Fig. 1F ) . Representative images from vehicle-treated mice demonstrated widespread swollen mitochondria with ruptured outer membranes (arrowheads). Matrix paling and disrupted cristae were associated with vacuolation of the internal compartment. These changes were significantly attenuated in ResV-treated animals ( Table 1) .
Transcriptional Response to ResV in CLP-Induced Myocardial Depression
We used GSEA to look for coordinated expression within treated samples of 18,586 most variable probes filtered using one-class analysis in SAM (corresponding to 14,828 genes, false discovery rate < 0.9%, delta 7.1888). ResV administration resulted in up-regulation of 121 gene sets, including various involved in bioenergy metabolism such as oxidative phosphorylation, mitochondrial, ribosomal structure and function, and pyrimidine metabolism (Fig. 2, Table 2, and Supplemental Table  2 [Supplemental Digital Content 5, http:// links.lww.com/CCM/A422], respectively). ResV treatment resulted in upregulation of gene sets associated with known pathological mitochondrial neurological dysfunction conditions (Parkinson's, Alzheimer's, and Huntington's disease), detoxification, and management of oxidative stress. The putative impact of changes in gene expression in specific pathways was visualized using Ingenuity Pathway Analysis (Fig. 3) . Treatment with ResV leads to very specific upregulation of individual components of complexes I, II, and III, as well as partial upregulation of complex IV and Y secretases (combined gene list presented in Supplemental In contrast, down-regulated gene sets (54 gene sets) included sets previously known to play a role in pathological heart conditions associated with arrhythmias, sodium reabsorption, dilated, and hypertrophic cardiomyopathy (Fig. 4 , Table 3 , and Supplemental Table 3 , Supplemental Digital Content 6, http://links.lww.com/ CCM/A423; and Supplemental Table 6 , Supplemental Digital Content 9, http:// links.lww.com/CCM/A426). ResV treatment also led to down regulation of critical pathways involved in insulin signaling (Supplemental Fig. 3 , Supplemental Digital Content 14, http://links.lww.com/CCM/ A431; and Table 7) , mitogen-activated protein kinase signaling (Supplemental Fig. 4 , Supplemental Digital Content 15, http:// links.lww.com/CCM/A435; and Table 8 ), myocardial inflammation (viral myocarditis), and response to stress (Table 3  and Supplemental Table 3 , Supplemental Digital Content 6, http://links.lww.com/ CCM/A423).
ResV treatment resulted in enrichment for genes known to be regulated by PGC-1 (Fig. 5) . We compared these genes with genes known to be PGC-1 responsive in the MitoCarta inventory of mammalian mitochondrial genes (29) . Data for all genes enriched in sepsis-induced myocardial depression after ResV treatment and MitoCarta documented PGC-1 induction are presented in Supplemental Table 9 (Supplemental Digital Content 12, http:// links.lww.com/CCM/A429). The top net-). The top network identified by Ingenuity Pathway Analysis as ResV responsive included PGC-1-dependent genes specifically involved in neurological diseases, skeletal and muscle disorders (Fig. 5C ).
Our data strongly suggest that administration of ResV restores transcription of bioenergy metabolism, substrate utilization, oxidative stress, and detoxification pathways associated with both mitochondrial and cardiac pathological conditions.
Effects of ResV on the Expression of PGC-1-Related Genes and Transcription
Factors. We assessed the expression of PGC-1 related genes and transcription factors by quantitative real-time polymerase chain reaction in whole hearts collected at 48 hrs (Fig. 6 ). Relative change in gene transcription is expressed as a ratio of gene expression in treated (CLP) vs. sham samples (nonseptic mice). Expression values were normalized to glyceraldehyde-3-phosphate dehydrogenase. ResV treatment significantly increased the expression of PGC-1, iNOS and Nos3 and Forkhead box O3 (Foxo3). Expression of myocyte enhancing factor and nuclear factor erythroid-derived In the bottom row, high magnification image of a cross section of myocardium highlights changes in mitochondrial cristae morphology in CLP-vehicle-treated mice with development of membrane swelling and loss of structural integrity (ii). Lysosome (Ly) is seen surrounded by mitochondria. Higher magnification image of mitochondrial-myofibril unit underscore sepsis-induced changes in structural integrity. Normal structural integrity of the mitochondrial-myofibril units is noted in sham-treated mice (iv). CLP-induced myocardial dysfunction is associated with altered mitochondrial structure. The mitochondria are swollen. There is blebbing of the mitochondrial membrane (arrowheads) and sarcolema with cytoplasmic vacuolations (v). Clumping of the chromatin material is also noted as well as deposition of electron dense granules (EDG). In ResV-treated mice, mitochondrial structure is better preserved. The organelle are dense and unswollen (iii). The nuclear chromatin is dispersed and the sarcolemma does not show blebs (vi). The alterations observed in the individual animals are rated as 1 (normal) to 4 (severe). Table describing electron microscopy assessment of morphological and ultrastructural changes in murine hearts exposed to a model of polymicrobial sepsis (cecal ligation and puncture) treated with either vehicle or resveratrol.
2-like 2 (Nrf2) was significantly lower in the ResV-treated animals.
Gene Set Enrichment Analysis of cis-Regulatory Motifs
To identify common features among ResV-regulated genes, we used GSEA to screen the 4-kb segment centered on the transcription start site and 3 region for known transcription factor binding sites contained in the Molecular Signatures DataBase (MolSigDB, C3 data base).
While a total of 174 gene sets for known putative transcription factor binding sites were enriched in the vehicle-treated group (Supplemental Table  10 , Supplemental Digital Content 13, http://links.lww.com/CCM/A430), only three gene sets were enriched by treatment with ResV, all for unknown putative transcription factor binding sites. Downregulated gene sets were enriched for PGC-1 related transcription factors: Nrf2, Mef2, Foxo3, Foxo4, Err1, and Pparg. Importantly, treatment with ResV also led to down regulation of putative inflammation related transcription factors nuclear factor- (NF-), activator protein 1 (AP1) and CCAAT-enhancerbinding proteins binding sequences (Supplemental Table 10 
PGC-1a and Nrf2 Protein Expression in Heart Tissues and Cardiomyocytes
Exposure to ResV results in increased PGC-1 and decreased Nrf2 expression, which was confirmed by Western blot in heart tissue from wild-type mice exposed to CLP treated with vehicle or ResV for 48 hrs (Fig. 6B) . To determine the effects of ResV treatment on primary cardiomyocytes, cells were isolated from neonatal Sprague-Dawley rat hearts. Primary cardiomyocytes were treated with LPS (1 μg/ mL), ResV (50 μM), LPS + ResV or vehicle alone for 48 hrs. Untreated (control) cells express basal levels of PGC-1 and Nrf2. Similar to results from tissues, ResV treatment results in increased PGC-1 and decreased Nrf2 expression. In cells exposed to LPS, PGC-1 expression is List of top canonical pathways gene sets from Molecular Signatures Database found to be enriched in hearts from mice exposed to cecal ligation and puncture treated with resveratrol (contains genes that are up-regulated in the presence of resveratrol). List of top canonical pathways gene sets from Molecular Signatures Database found to be enriched in hearts from mice exposed to cecal ligation and puncture treated with vehicle (contains genes that are down-regulated in the presence of resveratrol).
reduced and Nrf2 protein expression is increased. Treatment with ResV results in increased PGC-1 and decreased Nrf2 protein expression (Fig. 6C) .
DISCUSSION
In keeping with previous findings from our group, at 48 hrs, CLP induced significant decrease in myocardial contractile function (8) . This was accompanied by moderate-to-severe loss of mitochondrial integrity, swelling, destruction of myofibrils associated with myocardial injury, and decreased PGC-1 transcription, expression, and function. Treatment with ResV increased PGC-1 expression and function, rescued mice from severe ultrastructural damage, and preserved myocardial contractile function; however, it did not result in a change in mortality at 48 hrs.
Over the past decade, the issue of adaptive vs. maladaptive responses to sepsis has led to the central thesis that decrease in mortality and recovery would be contingent upon adequate early maintenance, or subsequent restoration, of mitochondrial function to meet metabolic energy demands enabling cells to fulfill critical roles, including calcium homeostasis, maintenance of cellular redox state, and cell signalling (4). Although we do not know the exact cause of death in the animals that died post-CLP, our data suggest that in the first 2 days of severe sepsis, other factors (such as neuroimmunoregulatory responses) extending beyond preservation of contraction-dependent bioenergy metabolism may contribute to mortality. These findings may have important clinical and therapeutic implications, i.e. the molecular determinants of sepsisinduced cardiomyopathy may not be the same as the molecular determinants of death from sepsis-induced multiorgan failure.
We have previously shown that loss of PGC-1 messenger RNA and protein is a critical event associated with the advent and severity of sepsis-induced myocardial depression (17) . Moreover, increase in PGC-1 abundance and function precedes recovery of mitochondrial function, metabolic rate, and physiologic and biochemical organ function (31) . Exercise and physiological hypertrophy activate muscle PGC-1α by protein phosphorylation (32) . This modification increases PGC-1 protein stability, promotes its nuclear translocation, and precedes increases in its messenger RNA abundance (33) (34) (35) . In contrast, binding of PGC-1 to the p65 subunit of NF-kB (Rel a) represses PGC-1 activity leading to reduction in pyruvate dehydrogenase 4 expression and subsequent increase in glucose oxidation observed during proinflammatory states (36) . Although we did not figure 3. Upregulation of genes involved in mitochondrial dysfunction. Genes contributing to mitochondrial-related functional gene set enrichment were inputted into Ingenuity Pathway Analysis (IPA). IPA library of canonical pathways identified mitochondrial dysfunction as a top pathway altered in murine septic hearts after treatment with ResV. Molecule from the data set (gene list presented in Supplemental Table 4 , Supplemental Digital Content 7, http://links. lww.com/CCM/A424) that were associated with Ingenuity's Knowledge Base were considered for the analysis. The significance of the association and between the data set and the canonical pathway was determined in two ways: i) ratio of the number of molecules from the data set that map to the pathway divided by the total number of molecules that map to the canonical pathway (ratio 0.126) and ii) Fisher's exact test was used to calculate a p-value determining the probability that the association between the genes in the data set and the canonical pathway can be explained by chance alone (3.47 E
16
). By convention, up-regulated genes are shown in red and down-regulated genes are shown in green. Legend for IPA diagram is presented with supplemental material. figure 4. Downregulation of genes involved in myocardial dysfunction. A, Gene Set Enrichment Analysis (GSEA) enrichment plot for genes involved in dilated cardiomyopathy (GSEA KEGG pathways, Table 3 ). As described in Figure 2 , top part of each plot shows the progression of the running enrichment score and the maximum peak therein. The middle part shows the genes in the gene set as "hits" against the ranked list of genes. The lower part shows the histogram for the ranked list of all genes in the expression data set. B, The corresponding heat maps show the expression values for the top subset of genes in each pathway that contributes to the enrichment score in the 8 mice profiled. Results are converted to color, where red indicates a high and blue a low expression value. False discovery rate (FDR); gene symbols are described in Supplemental Table 6 (Supplemental Digital Content 9, http://links.lww.com/ CCM/A426). C, IPA library of canonical pathways identified myocardial hypertrophy as a top pathway altered in murine septic hearts after treatment with ResV (ratio 0.069, p-value 8.0E 17 ). Figure legend as described in Figure 3 . By convention, red is up-regulated and green is down-regulated. improvement in myocardial contractility and mitochondrial function is due to preservation of existing mitochondria or increased mitochondrial biogenesis and turn over. We documented increased expression of Tfam (transcription factor A mitochondria) and genes containing putative NRF1 (mitochondrial biogenesis) binding regulatory sequences. But other mitochondrial related proteins critical to mitochondrial biogenesis such as PPAR and -γ were not altered. Consistent with our findings, transcriptional activity favouring up-regulation of critical components of the respiratory complex subunits was significantly increased after ResV treatment and is associated with improved myocardial function and survival (16, 37) . Although we saw dramatic changes in myocardial structure and function, it is still possible that we were not powered to detect a significant improvement in survival after only 48 hrs. Alternatively, it is possible that myocardial depression is not the determining factor with respect to mortality from severe sepsis. In this study, we did not treat our animals with antibiotics. A more clinically relevant model may limit early deaths and unmask a significant effect of ResV on mortality at later time points. Further insight into this issue may be of fundamental importance to drug development for sepsis.
Using microarray analysis, we were able to determine that ResV treatment favored upregulation of genes within pathways related to bioenergy metabolism important for reversing oxidative phosphorylation dysfunction including genes encoding for components of the electron transport chain In contrast, down-regulated functional groups implicated genes involved in PGC-1 cotranscriptional activity such as Nrf2, myocyte enhancing factor2, Foxo4, Err1, and PPAR. This is in agreement with the findings from GSEA that identified up-regulated gene sets involved with detoxification and downregulation of genes involved in pathological cardiac conditions. Our findings are widely supported by the literature implicating PGC-1 as a critical protection factor mitigating pathological cardiomyopathy and hypertrophy (32, 38, 39) .
Of specific interest is the role of ResV in down-regulating the proinflammatory response. In this study, genes involved in mitogen-activated kinases as well as NF-B, activator protein 1, nuclear factor of activated T-cells, and cAMPresponsive transcription factor signaling were down-regulated by ResV treatment. Various studies support an anti-inflammatory role for ResV (40) (41) (42) . This may in fact be related to ResV induced increased in nitric oxide synthesis (43) . In the heart, ResV has been shown to increase nitric oxide production by enhancing endothelial nitric oxide synthase expression while simultaneously reducing nitrosilation by inhibiting key enzymes involved in this process (44) . In our study, ResV also led to an increase in iNOS expression. Reports on the effects of ResV on iNOS activity are controversial. While some studies report ResV-induced decrease in iNOS expression (45) , others report an increase in iNOS expression (46) . In fact, ResV was unable to protect kidney, brain, and heart cells from ischemia-reperfusion injury in iNOS knockout mice (47) .
Treatment with ResV has been shown to attenuate echocardiographic changes associated with pathological myocardial hypertrophy as well as dilatation (48) (49) (50) . Salutary effects have been associated with its effect on cardiac remodeling (51, 52) . In keeping with our findings, ResV may also attenuate arrhythmias associated with myocardial injury (53) .
In this study mitochondrial function was not measured. However, it has been shown that ResV increases citrate activity (54) and, as in our study, restores expression of components of mitochondrial complex I, II and III (55) . Given the preservation of mitochondrial structure, increased transcriptional activity of genes involved in detoxification, management of oxidative stress, and oxidative phosphorylation as well as decrease in markers of increased oxidative stress (Nrf2 activity), we would expect that the ResV-treated group will have a higher energy production than their disrupted counterparts in the vehicle-treated group. Furthermore, given we were unable to examine the structure and function of hearts in those animals that died, our study is biased toward survivors. A time course experiment would enable critical understanding of molecular changes associated with increased mortality.
CONCLUSION
In conclusion, the salutary effects of ResV on CLP-induced myocardial dysfunction are associated with increased PGC-1 abundance and function. Preservation of myocardial energy production capacity, prevention of secondary injury, mitigation of inflammation, and reversal of sepsis-induced myocardial remodeling are likely to underlie its beneficial physiological and histopathological effects. Future studies will be fundamental to determine whether these effects can change outcome.
